An integrated encyclopedia of DNA elements in the human genome.

Vertebrate Genomics Group, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
Nature (Impact Factor: 41.46). 09/2012; 489(7414):57-74.
Source: PubMed


The human genome encodes the blueprint of life, but the function of the vast majority of its nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) project has systematically mapped regions of transcription, transcription factor association, chromatin structure and histone modification. These data enabled us to assign biochemical functions for 80% of the genome, in particular outside of the well-studied protein-coding regions. Many discovered candidate regulatory elements are physically associated with one another and with expressed genes, providing new insights into the mechanisms of gene regulation. The newly identified elements also show a statistical correspondence to sequence variants linked to human disease, and can thereby guide interpretation of this variation. Overall, the project provides new insights into the organization and regulation of our genes and genome, and is an expansive resource of functional annotations for biomedical research.

Download full-text


Available from: Veronika Boychenko, May 19, 2014
  • Source
    • "Conversely, we genetically activated NF-kB signaling through expression of a constitutively active form of RELA (RELA S536E) (Hu et al., 2004), which promoted erlotinib resistance (Figure S3D). Using these tools, we defined a set of NF-kB target genes that, through differential expression analysis of the transcriptome data, were both activated by the expression of RELA S536E and suppressed by IkBSR expression , and that were established direct transcriptional targets of NF-kB in the ENCODE dataset (Bernstein et al., 2012; Figure S4A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although oncogene-targeted therapy often elicits profound initial tumor responses in patients, responses are generally incomplete because some tumor cells survive initial therapy as residual disease that enables eventual acquired resistance. The mechanisms underlying tumor cell adaptation and survival during initial therapy are incompletely understood. Here, through the study of EGFR mutant lung adenocarcinoma, we show that NF-κB signaling is rapidly engaged upon initial EGFR inhibitor treatment to promote tumor cell survival and residual disease. EGFR oncogene inhibition induced an EGFR-TRAF2-RIP1-IKK complex that stimulated an NF-κB-mediated transcriptional survival program. The direct NF-κB inhibitor PBS-1086 suppressed this adaptive survival program and increased the magnitude and duration of initial EGFR inhibitor response in multiple NSCLC models, including a patient-derived xenograft. These findings unveil NF-κB activation as a critical adaptive survival mechanism engaged by EGFR oncogene inhibition and provide rationale for EGFR and NF-κB co-inhibition to eliminate residual disease and enhance patient responses. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
    Full-text · Article · Apr 2015 · Cell Reports
  • Source
    • "To explore further whether BRCA1 binding at TR is associated with transcription termination, we searched for evidence of the co-localization at termination sites of BRCA1 peaks and RNAPII paused at the 3 0 end of the relevant genes (RNAPII S2P) (Davidson et al., 2014). Here we used ENCODE RNAPII CTD Ser2-P ChIP-seq data (Consortium, 2012). This analysis showed that more than 70% of BRCA1 peaks within TRs overlap paused RNAPII (Figure 5D and Table S1), suggesting that BRCA1 is actively engaged in transcription-associated events at termination sites. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The mechanisms contributing to transcription-associated genomic instability are both complex and incompletely understood. Although R-loops are normal transcriptional intermediates, they are also associated with genomic instability. Here, we show that BRCA1 is recruited to R-loops that form normally over a subset of transcription termination regions. There it mediates the recruitment of a specific, physiological binding partner, senataxin (SETX). Disruption of this complex led to R-loop-driven DNA damage at those loci as reflected by adjacent γ-H2AX accumulation and ssDNA breaks within the untranscribed strand of relevant R-loop structures. Genome-wide analysis revealed widespread BRCA1 binding enrichment at R-loop-rich termination regions (TRs) of actively transcribed genes. Strikingly, within some of these genes in BRCA1 null breast tumors, there are specific insertion/deletion mutations located close to R-loop-mediated BRCA1 binding sites within TRs. Thus, BRCA1/SETX complexes support a DNA repair mechanism that addresses R-loop-based DNA damage at transcriptional pause sites. Copyright © 2015 Elsevier Inc. All rights reserved.
    Full-text · Article · Feb 2015 · Molecular Cell
  • Source
    • "Similarly, the ENCODE project has data for several human postmortem brain regions ( (Bernstein et al., 2012). As a part of the mouse ENCODE project, epigenomic and gene expression assays have been performed on forebrain, midbrain, hindbrain, and a number of other brain regions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Long-lived post-mitotic cells, such as the majority of human neurons, must respond effectively to ongoing changes in neuronal stimulation or microenvironmental cues through transcriptional and epigenomic regulation of gene expression. The role of epigenomic regulation in neuronal function is of fundamental interest to the neuroscience community, as these types of studies have transformed our understanding of gene regulation in post-mitotic cells. This perspective article highlights many of the resources available to researchers interested in neuroepigenomic investigations and discusses some of the current obstacles and opportunities in neuroepigenomics.
    Full-text · Article · Jan 2015
Show more